We have often discussed the nefarious impact of rebates to middlemen, which is possibly the primary cause of inflated drug prices in the US. It appears that the US Dept of Health and Human Services is now targeting these rebates:
[EDIT] I’ll be adding more links as more sites cover the info. But it is not quite as clear-cut as I originally thought. The CNN story shows a more complicated outline for the proposal. And, as @Sam pointed out below, it only directly applies to Medicare/aid, and would need companion legislation to apply to private insurance.
Business Insider, my favorite site for medicine price articles:
Wall Street Journal (behind paywall):
[MODS EDIT] This topic is an important one for all of us. But the forum also has a strict line on restricting political discussions to the politics subcat ONLY (which does not update the front page) because of past incidents. For the purpose of this thread:
- it is perfectly appropriate to discuss the issues and the plans
- it is not appropriate to discuss political affiliations and calculations. Posts deemed too political will be moved to the politics category.
Please make it possible for us to keep this thread going civilly and intelligently!